Introduction: FOXO4-DRI peptide allows selective apoptosis of senescent cells, supports metabolic research, and assures balance in study, maximizing reproducibility and advancing growing old and oncology investigations. day-to-day laboratory workflows typically reveal gaps exactly where existing compounds fall short to deal with mobile senescence